我們已在上線! 進一步了解
CELUW圖示

Celularity Inc

已下市

CELUW已於2026年7月17日下市。

 

關於: Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

員工: 115

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於CELUW的最新新聞文章。

價格圖表採用Lightweight Charts™實作